BlackRock discloses QIAGEN stake of 12.69% of voting rights after October 21 deals
BlackRock reported holding 11.36% of capital and 12.69% of voting rights in QIAGEN N.V. after transactions on October 21, 2026. The filing was published by the AFM.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
BlackRock, Inc. notified a stake in QIAGEN N.V. following transactions on October 21, 2026. The notification appeared in the register of the Dutch regulator AFM, and Reuters distributed it on October 23.
The total holding amounts to 11.36% of capital and 12.69% of voting rights. The real indirect holding is 8.84% of capital and 9.98% of voting rights, while the potential indirect holding is 2.53% and 2.71% respectively.
why it matters
For markets this is a routine disclosure: it shows the ownership structure of QIAGEN shares and contains no new financial results from the company. Potential positions relate to options and contracts for difference, so the total stake can change as those instruments are settled.
tags
instruments
sources
- PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG — Reuters, 23 October 2026 at 20:06 UTC
- Release according to Article 40, Section 1 of the WpHG — Reuters, 23 October 2026 at 20:06 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗